Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as a solvent for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l; glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as solvent for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l; glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as solvent for intravenously administered drugs where compatibility has been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 6.24 g/l; potassium chloride, quantity: 0.4 g/l; calcium chloride dihydrate, quantity: 0.27 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established. indications as at 22 august 2005 : compound sodium lactate solution is particularly suitable for replacement of extracellular fluid loss where isotonic dehydration is evident and in burn therapy.

Malta - English - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 2.5 mg/ml - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun medical limited - glucose; sodium chloride - solution for infusion - 0.18 and 4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. 0.9% sodium chloride injection usp is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% sodium chloride injection usp is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells. sodium chloride injection usp is also indicated as a pharmaceutic aid and diluent for the infusion of compatible drug additives. refer to prescribing information accompanying additive drugs. this solution is contraindicated where the administration of sodium or chloride could be clinically detrimental. directions for use of plastic container caution: do not use plastic container in series connection. to open check for minute leaks by squeezing solution container firmly. if leaks are found, discard solut

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - gentamicin sulfate, quantity: 1.39 mg/ml (equivalent: gentamicin, qty 1 mg/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - for the treatment of infections due to one or more susceptible strains of bacteria, including pseudomonas aeruginosa, proteus species (indole positive and indole negative), escherichia coli, klebsiella, enterobacter and serratia species and staphylococcus (including strains resistant to other antibiotics). gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, septic abortion and burns complicated by sepsis. aminoglycosides, including gentamicin are generally not indicated in uncomplicated initial episodes of urinary tract infection unless the causative organisms are not susceptible to less toxic antibiotics. in suspected or documented gram-negative sepsis, gentamicin should be considered for initial antimicrobial therapy. therapy may be instituted before obtaining results of susceptibility tests. the decision to continu

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun medical, sa - sodium chloride - solution for infusion - 0.9 g/100ml - electrolytes - bovine, canine, caprine, equine - food, feline, ovine, porcine - electrolytes